Nektar settles university patent fight
Nektar Therapeutics has agreed to settle a patent suit filed by the University of Alabama in Huntsville for $25 million. The dispute centered on the work of Milton Harris, who started a company Nektar bought five years ago for $197 million. Harris had worked at the university and the university claimed ownership of Harris' patents. In the agreement, Nektar and Harris jointly paid $15 million to the university while Nektar agreed to pay $1 million a year for 10 years. In return, the university is dropping its claims to the PEGylation patent portfolio.
- here's the AP report on the settlement
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness


